Title: Cystic Fibrosis Year in Review 2025
Authors Sophia T. Pallenberg, Ester Zamarrón de Lucas, Andrea Párniczky, Raquel Lopes de Bragança
References 2026 Mar;25(2):198-203. doi: 10.1016/j.jcf.2026.02.010.
Keywords Cystic fibrosis, Year in review, CFTR modulators, ETI, Lung infections, Inflammation, Emerging therapies
Title: Changes in Body Weight and Cholesterol After Starting ETI: A Scoping Review
Authors Anna Walsh, Clodagh Landers, Niamh Lucey, Oonagh Griffin, Suzanne Carter, Clare Corish
References 2026 Mar 20:S1569-1993(26)00044-5. doi: 10.1016/j.jcf.2026.02.015.
Keywords Cystic fibrosis, Elexacaftor/tezacaftor/ivacaftor, ETI, Body mass index, Body composition, Serum lipids, Cholesterol
Title: How many exacerbations someone had last year predicts how many they will have this year, even when taking a modulator
Authors D. R. VanDevanter, C. O'Rourke, M. W. Konstan, J. P. Clancy, N. Mayer-Hamblett
References 2026 Mar;25(2):204-209. doi: 10.1016/j.jcf.2025.11.010. Epub 2025 Nov 29
Keywords Cystic fibrosis, Pulmonary exacerbations, CFTR modulators, Elexacaftor/tezacaftor/ivacaftor, Risk prediction, patient registry, clinical trials
Title: What Influences COVID-19 Severity After Transplant: Lessons From a Global Study
Authors Julie Semenchuk, Yumi Naito, Susan C. Charman, Siobhán B Carr, etc, Anne L. Stephenson on behalf of the Global CF Registry Collaboration
References 2026 Mar 11:S1569-1993(26)00038-X. doi: 10.1016/j.jcf.2026.02.009
Keywords COVID-19, Cystic fibrosis, Pandemic, SARS-CoV-2, Coronavirus, transplantation
Title: Is the multiple breath washout test reproducible in adults with cystic fibrosis?
Authors Chantal Darquenne, Janelle M. Fine, Ann R. Elliott, Douglas J. Conrad and Rebecca J. Theilmann
References 2026 Mar;25(2):272-278. doi: 10.1016/j.jcf.2026.02.003. Epub 2026 Feb 11.
Keywords Cystic fibrosis, Lung function, Multiple breath washouts
Title: Different Drugs, Different Results: What New CF Treatments Can Offer
Authors Noelia Rodriguez Mier, Isabelle Callebaut, Marijke Proesmans, Eva Van Braeckel, Stephanie Van Biervliet, Mieke Boon, Anabela Santo Ramalho, François Vermeulen
References 2026 Mar;25(2):314-318. doi: 10.1016/j.jcf.2025.12.018. Epub 2025 Dec 31.
Keywords CFTR modulators, Cystic fibrosis, Elexacaftor, In vitro functional assays, Patientderived intestinal organoids, Personalized therapy, Rare CFTR variants, Theratyping, Vanzacaftor